Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
News18 » India
1-min read

Cabinet Approves Promotion of Domestic Manufacturing of Medical Devices in Country

The expenditure to be incurred for the said schemes will be for the next five years i.e. from 2020-21 to 2024-25.

PTI

Updated:March 21, 2020, 6:46 PM IST
facebookTwitter Pocket whatsapp
Cabinet Approves Promotion of Domestic Manufacturing of Medical Devices in Country
(Image for representation/AP)

The government on Saturday approved a production-linked incentive (PLI) scheme for promoting domestic manufacturing of medical devices, with financial implications of Rs 3,420 crore.

The Union Cabinet headed by Prime Minister Narendra Modi also approved another promotion of medical device parks scheme worth Rs 400 crore for financing common infrastructure facilities in four medical device parks, an official statement said.

The expenditure to be incurred for the said schemes will be for the next five years i.e. from 2020-21 to 2024-25, it added.

"The Union cabinet has approved a scheme on promotion of medical device parks for financing common infrastructure facilities in four medical device parks with financial implications of Rs 400 crore, and approved the Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of medical devices with financial implications of Rs 3,420 crore," it said.

Under the sub-scheme for promotion of medical device parks, common infrastructure facilities would be created in four medical device parks, which is expected to reduce manufacturing cost of medical devices in the country.

"The PLI scheme for promoting domestic manufacturing of medical devices would boost domestic manufacturing and attract large investments in the medical device sector, particularly in the identified target segments. It will lead to expected incremental production of Rs 68,437 crore over a period of five years," the statement said.

The medical device sector suffers from a cost of manufacturing disability of around 12 per cent to 15 per cent, vis-a-vis competing economies, among other factors, on account of lack of adequate infrastructure, domestic supply chain and logistics, high cost of finance, inadequate availability of quality power, limited design capabilities and low focus on research and development activities (R&D) and skill development, etc.

There is, thus, a need for a mechanism to compensate for the manufacturing disability, it said.

It further said that the schemes have potential to generate an additional employment of 33,750 jobs over a period of five years and reduce import of target segments of medical devices.

Support the daily wage earners who have been hit the hardest by the COVID-19 crisis. Click here to contribute to the cause. #IndiaGives

The daily News18 Coronavirus COVID-19 newsletter - Get your copy here.

Subscribe to News18 Daybreak. Follow us on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube

Read full article

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results

India

  • Active Cases

    2,650

     
  • Total Confirmed

    2,902

     
  • Cured/Discharged

    183

     
  • Total DEATHS

    68

     
Data Source: Ministry of Health and Family Welfare, India
Updated: April 04 (09:00 AM)
Hospitals & Testing centres

World

  • Active Cases

    833,556

     
  • Total Confirmed

    1,127,528

     
  • Cured/Discharged

    234,023

     
  • Total DEATHS

    59,949

     
Data Source: Johns Hopkins University, U.S. (www.jhu.edu)
Hospitals & Testing centres